Explore New Technologies, Approaches to Disease at the BIO 2005 Business Forum, June 19-22

Jun 02, 2005, 01:00 ET from Biotechnology Industry Organization

    WASHINGTON, June 2 /PRNewswire/ -- The BIO 2005 Business Forum will
 provide a close-up look at the novel approaches biotech companies are taking
 to the world's most challenging health problems, including cancer, diabetes,
 neurodegenerative disorders, heart disease, infections and genetic disorders.
 More than 225 companies from around the world will give presentations at the
 Business Forum, and another 700+, including the top 20 global pharmaceutical
 companies, will also participate in partnering and other business development
     The BIO 2005 Business Forum runs June 19-22 at the Pennsylvania Convention
 Center in Philadelphia in conjunction with the BIO 2005 Annual International
 Convention.  At least 3,000 biotech, pharmaceutical and manufacturing
 executives are expected to participate.
     In addition to healthcare applications, the Business Forum will explore
 the technologies and business plans of companies developing agricultural,
 industrial and environmental biotech products.
     "The Business Forum is the largest, most comprehensive event of its kind
 in the world," said BIO President Jim Greenwood.  "It's the best opportunity
 of the year to explore the biotech pipeline, from early-stage research to
 near-market and marketed products.  Every established and emerging technology
 will be represented, including nanotechnology, RNA interference, stem cell
 therapy and systems biology."
     Greenwood added, "One of BIO's central missions is to help biotech
 companies build their businesses by exposing them to potential partners,
 investors and the media.  BIO 2005-the world's largest biotech gathering-is an
 ideal venue for the Business Forum."
     The BIO 2005 Business Forum is comprised of three components:  one-on-one
 partnering meetings, company presentations and a one-day executive workshop on
 corporate positioning.  The presentations kick off Monday, June 20 with
 speeches from representatives of several of the top 25 pharmaceutical
     For more information about the Business Forum visit
     Advance media registration for BIO 2005 is available online.  Registration
 is complimentary for credentialed members of the news media.  To register in
 advance, visit http://www.bio.org/events/2005/.  On site, only reporters and
 editors working full-time for print or broadcast news organizations may
 register with valid media credentials.  All freelancers and online
 publications must register in advance by June 10, 2005.
     BIO represents more than 1,100 biotechnology companies, academic
 institutions, state biotechnology centers and related organizations across the
 United States and 31 other nations.  BIO members are involved in the research
 and development of healthcare, agricultural, industrial and environmental
 biotechnology products.

SOURCE Biotechnology Industry Organization